Autoimmune Disease Diagnostics Market is expected to reach $7,146.32 million by 2034, growing at a CAGR of 4.9%

𝐓𝐡𝐞 𝐚𝐮𝐭𝐨𝐢𝐦𝐦𝐮𝐧𝐞 𝐝𝐢𝐬𝐞𝐚𝐬𝐞 𝐝𝐢𝐚𝐠𝐧𝐨𝐬𝐭𝐢𝐜𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 𝐰𝐚𝐬 𝐩𝐫𝐨𝐣𝐞𝐜𝐭𝐞𝐝 𝐭𝐨 𝐛𝐞 𝐰𝐨𝐫𝐭𝐡 𝐔𝐒𝐃 𝟒𝟒𝟑𝟑.𝟏𝟏 𝐦𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 𝟐𝟎𝟐𝟒. 𝐓𝐡𝐞 𝐦𝐚𝐫𝐤𝐞𝐭 𝐢𝐬 𝐚𝐧𝐭𝐢𝐜𝐢𝐩𝐚𝐭𝐞𝐝 𝐭𝐨 𝐫𝐢𝐬𝐞 𝐟𝐫𝐨𝐦 𝐔𝐒𝐃 𝟒𝟔𝟒𝟒.𝟗𝟑 𝐦𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 𝟐𝟎𝟐𝟓 𝐭𝐨 𝐔𝐒𝐃 𝟕𝟏𝟒𝟔.𝟑𝟐 𝐦𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 𝟐𝟎𝟑𝟒, 𝐰𝐢𝐭𝐡 𝐚 𝐜𝐨𝐦𝐩𝐨𝐮𝐧𝐝 𝐚𝐧𝐧𝐮𝐚𝐥 𝐠𝐫𝐨𝐰𝐭𝐡 𝐫𝐚𝐭𝐞 (𝐂𝐀𝐆𝐑) 𝐨𝐟 𝟒.𝟗% 𝐟𝐫𝐨𝐦 𝟐𝟎𝟐𝟓 𝐭𝐨 𝟐𝟎𝟑𝟒.

𝐌𝐚𝐫𝐤𝐞𝐭 𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰:
Autoimmune diseases develop when the immune system attacks and kills healthy tissue in our body. Diagnosing an autoimmune disease can be tricky because there is rarely a single test that can determine whether the patient has a specific autoimmune disease. Many autoimmune disorders have similar symptoms, which might be vague and intermittent. Two basic types of examinations are usually employed: medical history and physical examination. Aside from that, a number of medical tests can help diagnose an autoimmune disease, including the antinuclear antibody (ANA) test, immunoglobulin blood test, and rheumatoid factor test.

𝐆𝐞𝐭 𝐄𝐱𝐜𝐥𝐮𝐬𝐢𝐯𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐚𝐠𝐞𝐬 𝐨𝐟 𝐓𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭:
https://www.polarismarketresearch.com/industry-analysis/global-autoimmune-disease-diagnostics-market/request-for-sample

𝐅𝐚𝐜𝐭𝐨𝐫𝐬 𝐈𝐧𝐟𝐥𝐮𝐞𝐧𝐜𝐢𝐧𝐠 𝐆𝐫𝐨𝐰𝐭𝐡:
• The demand for the autoimmune disease diagnostics market is influenced by the increase in the prevalence of autoimmune illnesses significantly.
• The market for autoimmune disease diagnostics is expanding as a result of the increasing number of diagnosed cases, which calls for early and accurate diagnostic techniques to manage and treat these chronic disorders effectively.
• Tests for autoimmune illnesses are now far more accurate, efficient, and accessible thanks to technological developments in diagnostics, thereby boosting the autoimmune disease diagnostics market.

𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 𝐢𝐧 𝐌𝐚𝐫𝐤𝐞𝐭:
There are many different players in the market for autoimmune disease diagnostics, including large diagnostic companies, niche biotechnology companies, and up-and-coming startups. With an emphasis on innovation to improve early and accurate identification of autoimmune disorders, major players in the market provide a broad range of advanced diagnostic technologies and substantial product portfolios.

• Abbott
• AESKU.DIAGNOSTICS
• Beckman Coulter, Inc.
• BIOMÉRIEUX
• Bio-Rad Laboratories, Inc.
• EUROIMMUN
• F. Hoffmann-La Roche Ltd
• Inova Diagnostics (Werfen Group)
• Myriad Genetics, Inc.

𝐀𝐮𝐭𝐨𝐢𝐦𝐦𝐮𝐧𝐞 𝐃𝐢𝐬𝐞𝐚𝐬𝐞 𝐃𝐢𝐚𝐠𝐧𝐨𝐬𝐭𝐢𝐜𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬
• Based on type, the systemic autoimmune disease diagnostics segment dominated the autoimmune disease diagnostics market revenue share, mainly attributed to increased awareness among healthcare providers and patients.
• The antinuclear antibody (ANA) tests segment, by test type, is expected to register the highest CAGR during the forecast period, owing to the increasing prevalence of autoimmune diseases and advancements in diagnostic technologies.
• North America dominated the market due to advanced healthcare infrastructure and substantial funding for medical research and development.

𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐥 𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰:
• Based on type, the market for the autoimmune diagnostic market is segmented as systemic autoimmune disease diagnostics and localized autoimmune disease diagnostics.
• In 2024, systemic autoimmune disease diagnostics held global dominance owing to the fact that it requires comprehensive testing to detect a wide array of autoantibodies and biomarkers.
• Due to improvements in diagnostic methods and the rising incidence of autoimmune illnesses, the antinuclear antibody test segment dominated the market in 2024.

By Product Outlook (Revenue - USD Million, 2020-2034)
• Consumables and Assay Kits
• Instruments

By Type Outlook (Revenue - USD Million, 2020-2034)
• Systemic Autoimmune Disease Diagnostics
o Rheumatoid Arthritis
o Ankylosing Spondylitis
o Systemic Lupus Erythematosus (SLE)
o Others

• Localized Autoimmune Disease Diagnostics
o Multiple Sclerosis
o Type 1 Diabetes
o Hashimoto's Thyroiditis
o Idiopathic Thrombocytopenic Purpura
o Others

By Test Type Outlook (Revenue - USD Million, 2020-2034)
• Antinuclear Antibody (ANA) Tests
• Autoantibody Tests
• Complete Blood Count (CBC)
• Comprehensive Metabolic Panel
• C-Reactive Protein (CRP)
• Others

By End User Outlook (Revenue - USD Million, 2020-2034)
• Hospitals
• Diagnostics Centers
• Research Laboratories

𝐑𝐞𝐠𝐢𝐨𝐧𝐚𝐥 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬:

• North America (U.S., Canada)
• Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia)
• Asia Pacific (Japan, China, India, Malaysia, Indonesia. South Korea)
• Latin America (Brazil, Mexico, Argentina)
• Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)

𝐌𝐨𝐫𝐞 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐋𝐚𝐭𝐞𝐬𝐭 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐛𝐲 𝐏𝐨𝐥𝐚𝐫𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡:
Actinic Keratosis Treatment Market
https://www.polarismarketresearch.com/industry-analysis/actinic-keratosis-treatment-market

Immune Health Supplements Market
https://www.polarismarketresearch.com/industry-analysis/immune-health-supplements-market

Real World Evidence Solutions Market
https://www.polarismarketresearch.com/industry-analysis/real-world-evidence-solutions-market

Europe Laboratory Developed Tests Market
https://www.polarismarketresearch.com/industry-analysis/europe-laboratory-developed-tests-market

Technology Solutions In The U.S. Healthcare Payer Market
https://www.polarismarketresearch.com/industry-analysis/technology-solutions-in-the-us-healthcare-payer-market

𝐂𝐨𝐧𝐭𝐚𝐜𝐭:

Likhil G
8 The Green Ste 19824,
Dover, DE 19901,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Follow Us: LinkedIn | Twitter

𝐀𝐛𝐨𝐮𝐭 𝐏𝐨𝐥𝐚𝐫𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 & 𝐂𝐨𝐧𝐬𝐮𝐥𝐭𝐢𝐧𝐠, 𝐈𝐧𝐜:

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.

This release was published on openPR.